The bcl-2 family of proteins

British Medical Bulletin

Volumn 53, Issue 3, 1997, Pages 466-477

  Brown, Robin ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEINASE;

APOPTOSIS; B CELL LYMPHOMA; CELL SURFACE; ENZYME ACTIVITY; LEUKEMIA; ONCOGENE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

EID: 0030806550     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bmb.a011624     Document Type: Review

References (42)

1. Tsujimoto Y, Crossman J, Jaffe E, Croce C. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985; 228: 1440-3
2. Vaux D, Cory S, Adams J. Bcl-2 gene promotes haematopoeitic cell survival and co-operates with c-myc to immortalize pre-B cells. Nature 1988; 335: 440-2
3. Chen-Leavy S, Cleary ML. Membrane topology of the bcl-2 proto-oncogenic protein demonstrated in vitro. J Biol Chem 1990; 265: 4929-33
4. Hockenberry D, Nunez G, Milliman RD et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334-6
5. Tanaka S, Saito K, Reed J. Structure-function analysis of the apoptosis-suppressing bcl-2 oncoprotein: substitution of a heterologous transmembrane domain restores function to truncated bcl-2 proteins. J Biol Chem 1993; 268: 10920-6
6. Monaghan P, Robertson D, Amos AS et al Ultrastructural localisation of bcl-2 protein. J Histochem Cytochem 1992; 40: 1819-25
7. Jacobson MD, Burne JF, King MP et al. Apoptosis and Bcl-2 protein in cells without mitochondrial DNA. Nature 1993; 361: 365-8
8. Krajewski S, Tanaka S, Takayama S et al. Investigations of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 1993; 53: 4701-14
9. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ. BCL-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993; 75: 229-40
10. Nakayama K, Nakayama K-I, Negishi I et al. Targeted disruption of Bcl-2 ab in mice: occurence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc Natl Acad Sci USA 1994; 91: 3700-4
11. Kamada S, Shimono A, Shinto Y et al. Bcl-2 deficiency in mice leads to pleiotropic abnormalities: accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine. Cancer Res 1995; 55: 354-9
12. Motoyama N, Wang F, Roth KA et al. Massive cell death of immature haematopoetic cells and neurons in bcl-x-deficient mice. Science 1995; 267: 1506-9
13. Knudson CM, Tung KSK, Tourtellotte WG et al. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 1995; 270: 96-9
14. Yin X-M, Oltvai ZN, Korsmeyer SJ. BH1 and BH2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerisation with BAX. Nature 1994; 369: 321-3
15. Boyd JM, Gallo GJ, Elangovan B et al. Bik, a novel death-inducing protein shares a distinct sequence motif with bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 1995; 11: 1921-8
16. Hengartner MO, Horvitz HR. Activation of C. elegans cell death protein CED-9 by an aminoacid substitution in a domain conserved in Bcl-2. Nature 1994; 369: 318-20
17. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerises in vivo with a conserved homolog BAX, that accelerates programmed cell death. Cell 1993; 74: 609-19
18. Chittenden T, Harrington EA, O'Connor R et al. Induction of apoptosis by the bcl-2 homologue Bak. Nature 1995; 372: 733-6
19. Keifer MC, Brauer MJ, Powers VC et al. Modulation of apoptosis by the widely distributed bcl-2 homologue Bak. Nature 1995; 371: 736-9
20. Farrow SF, White JHM, Martinou I et al. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature 1995; 371: 731-3
21. Henderson S, Huen D, Rowe M et al. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of bcl-2, protects human B-cells from programmed cell death. Proc Natl Acad Sci USA 1993; 90: 8479-83
22. Wang H-G, Takayama S, Rapp UR et al. Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1. Proc Natl Acad Sci USA 1996; 93: 7063-8
23. Naumovski L, Cleary ML. The p53-binding protein 53BP2 also interacts with bcl-2 and impedes cell cycle progression at G2/M. Mol Cell Biol 1996; 16: 3884-92
24. Guan RJ, Moss SF, Arber N et al. 3OkDa phosphorylated form of bcl-2 protein in human colon. Oncogene 1996; 12: 2605-9
25. Haldar M, Jena N, Croce CM. Inactivation of bcl-2 by phosphorylation. Proc Natl Acad Sci USA 1995; 92: 4507-11
26. Metzstein MM, Hengartner MO, Tsung N et al. Transcriptional regulator of programmed cell death encoded by Caenorhabditis elegans gene ces-2. Nature 1996; 382: 545-7
27. Inaba T, Inukai T, Yoshihara T et al. Reversal of apoptosis by the leukemia-associated E2A-HLF chimeric transcription factor. Nature 1996; 382: 541-4
28. Walton MI, Whysong D, O'Connor PM et al. Constitutive expression of human bcl-2 modulates nitrogen mustard and campothecin induced apoptosis. Cancer Res 1993; 53: 1853-61
29. Miyashita T, Reed JC. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 1993; 81: 151-7
30. Fischer TC, Milner AE, Gregory CD et al. Bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res 1993; 53: 3321-6
31. Chiou S-K, Rao L, White E. Bcl-2 blocks p53-dependent apoptosis. Mol Cell Biol 1994; 14: 2556-63
32. Vaux DL, Aguila HL, Weissman IL. Bcl-2 prevents death of factor-deprived cells but fails to prevent apoptosis in targets of cell mediated killing, Int Immuol 1992; 4: 821-4
33. Darmon AJ, Nicholson DW, Bleakley RC. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 1995; 377: 446-8
34. Hengartner MO, Horvitz HR. Programmed cell death in Caenorhabditis elegans. Curr Opin Genet Dev 1994; 4: 581-6
35. Hegartner MO, Horvitz HR. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 1994; 76: 665-76
36. Hengartner MO, Ellis RE, Horvitz HR. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 1992; 356: 494-9
37. Munchmore SW, Sattler M, Liang H et al. X-ray and NMR structure of human Bcl-XL, an inhibitor of programmed cell death. Nature 1996; 381: 335-41
38. 2+ fluxes. Proc Natl Acad Sci USA 1994; 91: 6569-73
39. 2+. Oncogene 1996; 12: 2259-66
40. Krajewski S, Tanaka S, Takayama S et al. Investigations of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 1993; 53: 4701-14
41. Ameisen JC, Idziorek T, Billaut-Mulot O et al. Apoptosis in a unicellular eukaryote (Trypanosoma cruzi): implications for the evolutionary origin and role of programmed cell death in the control of cell proliferation, differentiation and survival. Cell Death Differ 1995; 2: 285-300
42. Christensen ST, Wheatley DN, Rasmussen MI et al. Mechanisms controlling death, survival and proliferation in a model unicellular eukaryote Tetrahymena thermophila. Cell Death Differ 1995: 2: 301-8